IFN-producing killer dendritic cells (IKDC) represent a recently discovered cell type in the immune system that possesses a number of functions contributing to innate and adaptive immunity, including production of type 1 and 2 IFNs, interleukin (IL)-12, natural killing, and ultimately antigen presentation to naïve T cells. Here, we compared in vitro and in vivo responses of mouse IKDC, conventional dendritic cells (DC), and natural killer (NK) cells to murine cytomegalovirus infection and found distinct functions among these cell subsets. Upon recognition of infected fibroblasts, IKDC, as well as NK, produced high level of IFN-;, but unlike NK, IKDC simultaneously produced IL-12p40 and up-regulated MHC class II (MHC-II) and costimulatory molecules. Using MHC-II molecule expression as a phenotypic marker to distinguish activated IKDC from activated NK, we further showed that highly purified MHC-II + IKDC but not NK cross-present MHC class I-restricted antigens derived from MCMV-infected targets to CD8 + T cells in vitro and in vivo. Our findings emphasize the unique nature of IKDC as a killer antigenpresenting cell directly linking innate and adaptive immunity.
Introduction
We and others have recently described a new subset of antigenpresenting cells (APC), termed IFN-producing killer dendritic cells (IKDC) or natural killer (NK) dendritic cells (DC) , that exhibit properties of both NK cells and DC (1) (2) (3) . In-depth phenotypic analyses established splenic IKDC as a homogeneous CD11c lo B220 + CD49b + population, distinct from murine NK by their expression of MHC class II molecules (MHC-II) and from DC by their expression of NK receptors. Upon stimulation in vitro with CpG oligodeoxynucleotides or in vivo with Listeria monocytogenes splenic IKDC killed typical NK targets and showed the unique ability to produce IFN-g, IFN-a, and interleukin (IL)-12 (1) . Activated IKDC further differentiated into DC-type APC that accumulated in vivo in lymph nodes (LN) to activate CD4 + T cells. IKDC also mediated melanoma rejection via an IFN-g and tumor necrosis factor (TNF)-related apoptosis-inducing ligand-dependent mechanism (2) .
The functional relationship between IKDC and DC and their distinction from NK cells has been challenged in recent reports suggesting that the phenotypic definition of IKDC based on CD11c, B220, and CD49b expression could not clearly distinguish them from activated NK (4) (5) (6) (7) . However, a recent study showed that, although sharing a lymphoid origin, IKDC and NK derive from distinct precursors (8) . We show here that IKDC, but not NK, cross-present mouse cytomegalovirus (MCMV)-encoded antigens, derived solely from MCMV-infected cells, in association with MHC-II and MHC-I to CD4
+ and CD8 + T cells, respectively. This functional capacity of mature IKDC, which were previously shown to accumulate in the LN (1), correlates with expression of genes encoding the MHC-II processing machinery, costimulatory molecules, and cosecretion of IL-12p40 and IFN-g at the single cell level. The antigen crosspresentation functions, together with their natural killing activity against both virally infected and tumor cells (1) , establish IKDC as a unique type of APC bridging innate and adaptive immunity.
Materials and Methods
Mice and reagents. BALB/c and C57BL/6 were purchased from National Cancer Institute and Harlan laboratories. IL-12p40 À/À mice were purchased from Jackson Laboratories. Myd88 OT-I, OT-II, Clone4, and 6.5 T-cell transgenic mice were maintained at Johns Hopkins University. Antibodies were purchased from BD Biosciences, except antibodies against NKG2D (CX5) and NKp46 (eBioscience). Intracellular staining (ICS) for cytokines was performend in presence of Brefeldin A using BD Biosciences Cytofix/Cytoperm reagent following manufacturer's recommendations. Fluorescence-activated cell sorting (FACS) analysis was done on FACSCalibur or LSR2 (BD Biosciences), and data were analyzed using FlowJo software (Tree Star, Inc). Sorting was performed on FACSAria (BD Biosciences). For some experiments, cells were activated with 6 Ag/mL CpG1668 (MWG Biotech). For Western blot analysis, anti-invariant chain (Ii;CD74; clone OX6; Santa Cruz) and anti-Legumain (Clone 301417; R&D systems) monoclonal antibodies (mAb) were used as primary antibodies, and anti-tubulin mAb as a control. Secondary antibody was sheep anti-mouse IgG labeled with horseradish peroxidase (enhanced chemiluminescence; GE Healthcare Lifesciences). IL-12p40 and IL-12p70 were measured in supernatant using ELISA (Pierce Endogen). Viruses. MCMV virus expressing green fluorescent protein (GFP; Dr. M. Messerle, Hannover Medical School, Hannover, Germany) and MCMV expressing HA (A/PR/8/34) or TfrOVA were previously described (9) (10) (11) . Primary fibroblasts were infected at multiplicity of infection of 3 for 1.5 h. Cells were washed and coincubated with splenocytes at a ratio 1 fibroblast: 10 splenocytes for 12 h. Infection was monitored by cytopathic effect and GFP expression.
Cell isolation. Cellular isolation was previously described (1 (Fig. 2D) .
Gene expression profile analysis. Total RNA was isolated from cellsorted IKDC, CDC, and NK using Trizol (Invitrogen) and RNeasy MicroKit (Qiagen). For Chip analysis, RNA was processed using a two round RNA amplification protocol described by Affymetrix and Affymetrix murine genome GeneChip array M0E430-2. The statistical significance of the fold change in gene expression has been analyzed using posterior P value. Fold changes of z2 and V0.5 associated with a probability of >0.5 were considered significant.
Confocal microscopy. Cells were fixed with 3% paraformaldehyde/ sucrose and permeabilized with 0.1% Triton-X. MHC-II were detected with anti-IA/E-biotin+AF594-streptavidin, CD49b with AF488 CD49b mAb and, for OVA crosspresentation assay, Kb/OVA SIINFEKL with AF647-labeled 25 Table S1 ; Fig. 1 ). Statistical computation of the fold change showed the preferential expression in LN IKDC versus NK of H2-I-A/I-E alleles, Ii, C2ta, and enzymes involved in Ii or antigen processing (cathepsins, IFN-ginducible lysosomal thiol reductase; Table 1 ; refs. [13] [14] [15] . We also detected ancillary components important for proper antigen processing, including H2-Dma and H2-Dmb1, Nox2 (Cybb), Cst3, and V-ATPase subunits (data not shown; Fig. 1 ; refs. [16] [17] [18] [19] . Splenic IKDC only exhibit a statistically higher expression of I-A and I-E alleles compared with NK. At the protein level, confocal microscopy confirmed that splenic IKDC, but not NK or CDC, coexpressed CD49b and MHC-II ( Fig. 2A) (Fig. 1B) .
The assertion that IKDC represent activated NK (5-7) predicts that, upon activation, NK or a subset among the total NK population will acquire properties and surface markers similar to IKDC. We cocultured the CD11c À fraction containing naïve NK Fig. 2C ). Costimulatory molecules were also upregulated on the surface of IKDC (data not shown; Fig. 3C ). These conditions induced a robust IFN-g production (Fig. 4) and upregulation of CD11c and B220 by NK ( Supplementary Fig. S1 ), indicating that the absence of MHC-II up-regulation did not reflect a failure of NK to recognize infected fibroblasts. It were FACS-sorted from BALB/c mice spleen to high purity and transferred into MCMV-infected NOD/severe combined immunodeficient/gc À/À mice. As shown in Fig. 2B , MHC-II expression on NK before transfer is essentially negative, whereas expression is low on IKDC. Although transferred NK indeed upregulated B220 and CD11c upon MCMV infection (37%), they failed to express any MHC-II (Fig. 2D ). In contrast, 5% to 6% of transferred IKDC expressed intermediate to high MHC-II levels, at day 2 and 3 postinfection. Altogether, these results show that differential expression of CD11c, B220, and NK1.1/CD49b allows for the distinction between naïve IKDC, NK, and CDC, whereas surface MHC-II expression should be included to delineate activated IKDC from activated NK. Therefore, to perform antigen presentation assays on sorted cell populations, we define IKDC activated during incubation with MCMV-infected fibroblasts or in vivo after MCMV injection as ( Supplementary Fig. S1 ), but remained MHC-II À and, therefore, were sorted as CD11c + NK1.1 + MHC-II À . IKDC derived from coculture with MCMV/OVA-but not MCMV/GFP-infected fibroblasts induced IL-2 secretion by OT-II CD4 + T cells (Fig. 3A) . Treatment of IKDC with CpG1668 stimulated a higher level of IL-2 by OVA-specific OT-II cells. CDC, but not NK, cultured with MCMV/OVA-infected fibroblasts were potent in inducing OT-II stimulation. Although low, IL-2 induction by IKDC still ranged between one third and one half of that by CDC (Fig. 3A) . We reproduced these findings using HA-specific 6.5 CD4 + T cells and MCMV/HA-infected fibroblasts (Fig. 3B) . As a control, IKDC incubated with OVA 323-339 or HA 110-120 induced less IL-2 than CDC ( Fig. 3A and B) . NK, which lacked MHC-II, did not stimulate CD4 + T cells. BALB/c MHC-II hi IKDC used for the presentation assay expressed accessory molecules such as CD80, CD86, and CD40 (Fig. 3C) . The high purity of each FACS-sorted population (>95%) ruled out the role of contaminating CDC in assays of T-cell activation by purified IKDC (Supplementary Fig. S3; Fig. 5 ). NK, which included similar percentages of contaminating CDC as did IKDC (1.2% for NK versus 1.0% for IKDC in Supplementary Fig. S3 ), did not stimulate T cells to produce IL-2. No IL-2 secretion was observed when sorted CD4 + T cells were incubated with peptide alone, ruling out their contamination with APC (data not shown). Reverse transcription-PCR performed on IKDC, NK, and CDC incubated with MCMV-GFP did not detect expression of viral genes ie1, m157, or GFP in IKDC (data not shown). Neither was free virus detected in the APC/fibroblast coculture in the timeframe of experiment (data not shown), indicating that IKDC and CDC rather ingested antigens from the infected target cells and presented the processed epitope in association with MHC-II.
Activated IKDC simultaneously produced IFN-; and IL12p40. We used ICS to examine the capacity of individual IKDC NOTE: Fold change, (À) (+). *Probeset from the Affymetrix murine genome GeneChip MOE430-2. cUp-regulated and down-regulated genes are highlighted in green and red, respectively. The criterion of significance was set as the posterior probability of >0.5. Fold changes highlighted in gray are not statistically significant. Absolute value of each probeset is provided in Supplementary Table S1. (Fig. 4A) ) produced IFN-g but not IL-12p40. Neither IFN-g nor IL-12p40 was detected in response to uninfected fibroblasts. Because IL-12p40 is common to IL-12p70 and IL-23, both cytokines were assessed by ELISA in supernatants of activated IKDC. Only IL-12p40 and IL-12p70 were detected (Supplementary Fig. S4A ; data not shown for IL-23). Using IL12p40 À/À CD11c + splenocytes cultured with infected fibroblasts, we found that IFN-g secretion by IKDC was not impaired in absence of IL-12/IL-23 signaling (Fig. 4B) . In contrast, the absence of toll-like receptor signaling in Trif and Myd88-deficient CD11c . These results show that IL-12 is not primarily involved in the production of IFN-g by IKDC. When transwells were used to separate sorted IKDC and infected fibroblasts, IFN-g production by IKDC was also abrogated (Supplementary Fig. S5 ), suggesting that IFN-g secretion required cell-to-cell interaction.
Activated IKDC, distinguished from NK by up-regulation of MHC-II and CD40, accumulated in spleen, LN, and liver, peaking in number at day 2 postinoculation with MCMV ( Supplementary  Fig. S6A ). IKDC retained their ability to secrete IFN-g and IL-12p40 in vivo (Supplementary Fig. S6B ). Quantitative real-time PCR performed on sorted activated populations detected similar IL12p40 and IL-12p35 gene expression between IKDC and CDC, whereas only IFN-g RNA was detectable in NK ( Supplementary  Fig. S4B ). As found with ICS, IKDC, but not CDC, simultaneously expressed IFN-g mRNA. Furthermore, phenotyping of IKDC in spleen and LN highlighted concomitant expression of NKassociated receptors and APC markers (Supplementary Fig. S6C ).
Activated IKDC, but not NK, cross-primed CD8 + T-cells. Confocal microscopy using 16-D25-11 mAb showed that, unlike NK, CDC and IKDC generate H2-K b /OVA SIINFEKL complexes when incubated in vitro with soluble OVA and IFN-a ( Supplementary  Fig. S7 ). We further sought to determine whether IKDC were able to cross-present MHC-I-restricted OVA SIINFEKL derived from MCMV/ OVA-infected fibroblasts (18, 20) + splenocytes cultured in the presence of MCMV/OVAinfected fibroblasts, were able to induce OT-I proliferation assessed by CFSE dilution (Supplementary Fig. S8A; Fig. 5 ). Minimal CFSE dilution was observed when IKDC were derived from CD11c + fraction cultured in presence of MCMV/GFP-infected fibroblasts (Fig. 5C) proliferation of OT-I. The number of T cells after culture with NK stimulators was one tenth that in IKDC wells. Meanwhile, the number of T cells remaining in CDC wells was nine times that in IKDC wells. Whereas Fig. 5 shows proliferation at 1:3 APC/T cell ratio, CDC but not IKDC were still able to induce OT-I proliferation at 1:10 ratio, suggesting that IKDC are less efficient in stimulating T cells (data not shown). Cell subsets were highly purified via two rounds of sorting and doublet exclusion to assure the absence of NK/DC aggregates (Fig. 5A) . NK included 2% CDC contamination (Fig. 5A) , which, nonetheless, was not sufficient to trigger OT-I proliferation (Fig. 5C ), indicating that T-cell proliferation cannot be attributed to the <0.7% contaminating CDC in the IKDC preparation. Homogeneous expression of CD49b and NK1.1 by sorted IKDC (>96%) excludes contamination by PDC. Figure 5B shows that MHC-II hi IKDC, but not activated NK, also homogeneously up-regulated CD40 (85%; Fig. 5B ), whereas both subsets expressed B220. The inability of activated NK to stimulate OT-I T cells does not reflect the lack of MHC-I expression because all three populations expressed comparable levels of H2-K b (Fig. 5B) . Perf
IKDC did not activate OT-I cells indicating that killing is required for IKDC to uptake and cross-present antigen (data not shown). Activated IKDC, CDC, and NK sorted from C57BL/6 mice infected with MCMV/OVA-or MCMV/GFP were used in direct ex vivo antigen detection assays (Supplementary Fig. S8B; Fig. 6 ). Although the proportion of MHC-II hi IKDC was higher in LN than spleen of infected mice ( Supplementary Fig. S4 ), sorting was performed on splenocytes to isolate higher number of activated IKDC. Each population was subjected to a stringent two round sorting and doublet exclusion to reach a z99% purity, especially avoiding contamination of IKDC with CDC (Fig. 6A) . Sorted IKDC homogeneously expressed high levels of I-Ab, CD40, CD49b, and NKG2D (Fig. 6A-B) , ruling out the presence of were FACS-sorted from gates 1, 2, and 3, respectively, and incubated with OVA-specific OT-II CD4 + T cells. IL-2 was measured by ELISA in day 3 culture supernatants. Oligodeoxynucleotides CpG 1668 was added or not to the culture to stimulate the APCs. APC were also incubated in presence of OVA 323-339 to stimulate OT-II. B, similar presentation assay was performed with HA antigenic model. The purity of sorted populations used in this assay is shown in Supplementary Fig. S3 Fig. S8C ). Under these conditions, IKDC and CDC, but not NK, freshly sorted from MCMV/OVA-infected mice were able to induce proliferation of CFSE-labeled Rag2 À/À OT-I T cells (Fig. 6C ) to a significantly greater degree than the same cells isolated from MCMV/GFP-infected mice. Here again, all populations expressed comparable levels of H2-K b (Fig. 6B ). Very few viable T cells were observed after a 4-day culture with NK (unlike IKDC and CDC) isolated from MCMV/OVA-and MCMV/ GFP-infected mice, and the percentage of CFSE + cells in these cultures (i.e., test versus background) are equivalent. The number of T cells remaining at the end of the culture in presence of NK stimulators was one fifth that in IKDC wells. Twice as many T cells were observed in the presence of CDC compared with IKDC at the end of culture.
Discussion
In this report, we further delineate the phenotypic and functional differences between NK and IKDC and provide evidence that, upon killing of their targets, IKDC, but not NK, can mature into fully competent APC that cross-prime naïve CD4 + and CD8 + T cells. First, our findings establish in vitro that cellular contact with MCMV-infected targets was mandatory for IKDC to upregulate MHC-II, costimulatory molecules, and to secrete IFN-g and IL-12p40. Second, activated IKDC, which remained MCMVfree, presented in vivo and in vitro antigens released from killed target cells to CD4 + and CD8 + T cells. Although IKDC have been recently affiliated to an activated NK (4, 5, 7) , the present report brings forward molecular (i.e., microarray analysis) and functional (i.e., T-cell proliferation assays) evidence clearly demonstrating that MHC-II expression by activated IKDC reflects a fully functional antigen processing Similarly to our viral infection model, Anderson's and Zitvogel's groups showed that cellular contact with tumor cells triggered up-regulation of MHC-II and costimulatory molecules and licensed IKDC to cross-present antigen to CD4 + and CD8 + T cells (21, 22) . Although activated by the tumor or MCMV, NK failed to function as an APC in both experimental situations. Although we established that killing of the target is mandatory for antigen processing and presentation by activated IKDC, the nature of the mechanism used by IKDC to capture OVA expressed by MCMV/ OVA-infected fibroblasts was not addressed. However, Zitvogel and colleagues found that ''licensed'' CD11b + IKDC engulfed soluble, but not cell-associated, OVA (22) .
We carefully monitored the purity of MHC-II hi IKDC, which homogeneously coexpressed NK1.1, CD40, and NKG2D (Fig. 6B) formally excluding contaminating PDC, CDC, or putative CD49b + APC as previously suspected to be responsible for stimulating CD4 + T cells (7) . We also showed that IKDC activated both in vitro with MCMV-infected fibroblasts and in vivo after i.p. injection of MCMV were unique in their ability to produce both IFN-g and IL-12p40 at the single cell level. Although expression of MHC-II, costimulatory molecules such as B7 family members (CD80, CD86, or B7-H1) and TNF family members (OX40L) has already been reported on mouse and/or human NK, the up-regulation of CD40 and production of IL-12p40 have been classically considered as the hallmarks of professional APC (4, (23) (24) (25) . Contrary to recent reports (3, 26, 27) , we have shown that IFN-g secretion by IKDC, but not NK, was IL-12-independent, but required toll-like receptor signaling because Myd88/Trif deficiency abrogated the production of IFN-g by IKDC. Altogether, these features show that IKDC represent a unique population functionally distinct from activated NK.
Although CDC stand as the archetypal professional APC (28), which induce the activation of naïve T lymphocytes, additional innate immune cells including PDC, macrophages, neutrophils, and NK can potentially accomplish this mission (23, 25, (29) (30) (31) (32) (33) . Although less efficient than CDC, we showed that IKDC express a variety of costimulatory and accessory molecules (CD80, CD86, CD40, and IL-12p40) and induce the cross-priming of naïve T cells. It is unclear why and how IKDC as well as other innate effectors exercise their APC properties in vivo to complement CDC functions. IKDC and the related NK DC dramatically proliferated and accumulated in the LN in response to pathogen infections including Listeria monocytogene (34) 5 and MCMV (Supplementary Fig. S4 ). IKDC were also found in the tumor bed of B16 melanoma-bearing mice treated with Gleevec/IL-2 and improved animal survival (2) . Activated IKDC recirculate to the LN where, as mature APC, they engage directly in cognate interactions with CD4 + and possibly CD8 + T-cells (1, 21) . Thus, IKDC may benefit the host via their ability to rapidly present antigens from infected or malignant cells that they kill. By comparison, CDC are mainly dependent on their cooperation with killer cells, including NK, IKDC, neutrophils, and macrophages, to obtain cell debris (35) or alternatively on the late necrosis or apoptosis processes triggered by ''suicidal'' stressed cells (36) . We observed a strong up-regulation on IKDC of B7-H1 ( Supplementary Fig. S6C ), described to interact with PD1 on activated T cells and regulate the immune response (37) . Zitvogel and colleagues have shown that blockade of B7-H1 dramatically enhances the capacity of IKDC to stimulate effector functions of cognate T cells (22) . This phenomenon suggests a putative role for IKDC in the regulation of T-cell function.
Activated human NK up-regulate MHC-II and stimulate antigenspecific CD4 + T cells (23, 25, 33) . Strikingly, our study showed that activated IKDC, unlike human NK, were additionally able to crosspresent antigens to CD8 + T cells. Therefore, we anticipate that putative activated human IKDC would be functionally distinct from activated NK. Recently, IFN-DC, generated in vitro by treatment of human monocytes with IFN-a, were shown to express CD56 and IFN-g (38) . These CD56 + IFN-DC exhibited potent cytotoxic activity and seemed to stimulate in vivo antigen-specific CD8 + T-cells. Another study described DC expressing perforin at the vicinity of tumor in vivo and showed their cytotoxic activity in vitro (39) . These cells represent potential human homologues of IKDC. However, only the identification of specific markers will allow the translation to human and the assessment of their therapeutic implications.
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